Purpose

Revolutionizing Drug Development with AI

Transforming Drug Discovery with Proven Success

Our unique AI-driven platform has already yielded tangible results with

16

New chemical entities in development, including 2 in clinical trial phase 1 and one in active clinical trial phase 2.

Accelerating Innovation for Unmet Medical Needs

Focused on oncology, autoimmune disorders, and central nervous system diseases,

We’re developing precision therapies that target the most challenging conditions, delivering hope to those who need it most.